BILE DUCT CANCER
Clinical trials for BILE DUCT CANCER explained in plain language.
Never miss a new study
Get alerted when new BILE DUCT CANCER trials appear
Sign up with your email to follow new studies for BILE DUCT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immunotherapy targets lingering cancer cells in pancreatic and other tumors
Disease control CompletedThis early-phase trial tested an experimental immunotherapy called ELI-002 in 25 people with KRAS-mutated pancreatic, colorectal, lung, ovarian, or bile duct cancers who had minimal residual disease (small amounts of cancer left after standard treatment). The goal was to see if t…
Matched conditions: BILE DUCT CANCER
Phase: PHASE1 • Sponsor: Elicio Therapeutics • Aim: Disease control
Last updated May 04, 2026 16:22 UTC
-
Less invasive surgery for pancreatic cancer: does it reduce complications?
Knowledge-focused CompletedThis study compared two surgical approaches for removing tumors in the pancreas and bile ducts: a less invasive (miniinvasive) method and traditional open surgery. Researchers looked at 320 adults aged 21-75 with resectable or borderline resectable cancers. The goal was to see wh…
Matched conditions: BILE DUCT CANCER
Phase: NA • Sponsor: State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC